Atrial Pathophysiology Differs in Black, White Stroke Patients
WEDNESDAY, Dec. 2, 2020 -- Differences in left atrial structure and pathophysiology are found between Black and White patients with ischemic stroke, according to a study published online Nov. 25 in Neurology.
Hooman Kamel, M.D., from Weill Cornell Medicine in New York City, and colleagues compared atrial cardiopathy phenotypes between Black and White ischemic stroke patients. Markers of atrial cardiopathy were assessed in the Greater Cincinnati/Northern Kentucky Stroke study. Electrocardiograms (ECGs) and reports of echocardiograms performed during stroke evaluation in the 2010/2015 study periods were obtained.
The researchers found that 2,391 of the 3,426 ischemic stroke cases in Black and White patients without atrial fibrillation or flutter had a left atrial diameter measurement. In unadjusted and adjusted models, Black race was associated with a smaller left atrial diameter (ß coefficient [95 percent confidence interval], −0.11 [−0.17 to −0.05] and −0.15 [−0.21 to −0.09], respectively). In 3,209 patients, P-wave terminal force in ECG lead V1 (PTFV1) measurements were available. In unadjusted and adjusted models, Black race was associated with greater PTFV1 (ß coefficient [95 percent confidence interval], 1.59 [1.21 to 1.97] and 1.45 [1.00 to 1.80], respectively).
"Our findings should not be taken to imply that these racial differences in people with stroke reflect innate biological differences," Kamel said in a statement. "Our findings suggest that the current standards for diagnosing left atrial disease that can lead to stroke may need to be updated. These standards were established in groups of exclusively White people and may not fully reflect the variety and complexity of how these acquired cardiac issues are manifested in all people."
Several authors disclosed financial ties to the pharmaceutical industry.
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Read this next
TUESDAY, Jan. 19, 2021 -- For inpatients with ischemic heart disease, redesign of decision pathways from default opt-in to opt-out of cardiac rehabilitation (CR) results in a...
THURSDAY, Jan. 14, 2021 -- Reduced emergency department visits for suspected cardiac disease during the COVID-19 pandemic peak in England are associated with a time-lagged...
THURSDAY, Jan. 14, 2021 -- Greater levels of moderate- to vigorous-intensity physical activity (MVPA) in midlife may protect against cerebrovascular sequelae in later life,...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.